NVO Novo Nordisk A S
Five-factor quant read, peer ranking, and the analyst team's own call.
8.0
composite/ 10
Value
computed
10.0
priced for 3.9% growth vs 20.4% delivered · +255% to base-case fair value
Quality
computed
6.0
Piotroski 3/8 · Altman grey zone · ROE 53% · interest covered 32x
Momentum
-
Defensive
-
Tactical
-
Descriptive, not predictive. Momentum, Defensive and Tactical are deciles within our liquid universe; Value and Quality are computed from filed financials. None of them forecasts a return - the model's out-of-sample AUC is published in the whitepaper.
Peer comparison
Composite score against sector peers · 1 names
NVO ranks #1 of 1 · peer average 8.0
No current desk call on NVO.
The factor scores above are computed; a full analysis is four analyst desks, a bull-vs-bear
debate and a risk committee, and takes about three minutes.
Automated, educational research - not investment advice, and not a recommendation to buy or sell any security.